Hugo Lam
Seasoned Leader in Data, Software, Bioinformatics, and AI
Experience
Career
2025Genentech
Distinguished Engineer, Data Engineering · 2025 – Present
2019HypaHub, Inc.
Chief Executive Officer · IP acquired by GaudiBio · 2019 – 2025
2017Roche
Head of Bioinformatics Research & Early Development · Roche Sequencing Solutions · 2017 – 2019
2014Roche
Senior Director of Bioinformatics · Roche Sequencing Solutions · 2014 – 2019
2016Roche
Head of Data Insights · Roche Sequencing Solutions · 2016 – 2017
2013Roche
Director of Bioinformatics · Bina Technologies, acquired by Roche in 2014 · 2013 – 2014
2011Personalis, Inc.
Project Manager, Computational Biology · IPOed - NASDAQ:PSNL · 2011 – 2013
201123andMe
Software Engineer · IPOed - NASDAQ:ME · 2011
2004The University of Hong Kong
Technology Officer · Center for E-Commerce Infrastructure Development · 2004 – 2005
2000PCCW
Programmer Analyst · SEHK: 8 · 2000 – 2004
Bio
Hugo has over 20 years of experience in software, bioinformatics, and genomics, including time at Roche (SW: ROG), Bina (acquired by Roche), Personalis (NASDAQ: PSNL), 23andMe (NASDAQ: ME), and PCCW (SEHK: 8). Prior to founding HypaHub, Hugo was Senior Director and Head of Bioinformatics at Roche. He is an alumnus of HKUST, Imperial College London, Yale University, Stanford Medical School, and Cambridge Judge Business School. He has published in over 40 publications with over 35,000 citations.